BioAegis Awarded BARDA Contract to Advance Development of Gelsolin, a Novel Host-Directed Human Protein, for Patients with Sepsis and Severe Infection
NORTH BRUNSWICK, N.J., June 29, 2021 (GLOBE NEWSWIRE) — BioAegis Therapeutics Inc., a clinical stage,…
Presentations.ai AI Slide Generator Automates Investor Pitch Decks and Sales PPTs for 12 Million Users – The AI PowerPoint Maker Scales Professional Slide Generation With Branding, Design and Data